Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

Hepatology

Volumn 42, Issue 4, 2005, Pages 802-808

  Mao, Tin Ky ^a   Lian, Zhe Xiong ^a   Selmi, Carlo ^a,b   Ichiki, Yasunori ^a   Ashwood, Paul ^a   Ansari, Aftab A ^c   Coppel, Ross L ^d   Shimoda, Shinji ^e   Ishibashi, Hiromi ^f   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MONASH UNIVERSITY   (Australia)

^e KYUSHU UNIVERSITY   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; FLAGELLIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INNATE IMMUNITY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; AGED; ANTIGENS, CD14; CYTOKINES; FEMALE; FLAGELLIN; HUMANS; LIGANDS; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS, BILIARY; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; OLIGODEOXYRIBONUCLEOTIDES; POLY I-C; RECEPTORS, CELL SURFACE; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 25844471675     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20859     Document Type: Article

References (32)

1. Talwalkar JA, Liodor KD. Primary biliary cirrhosis. Lancet 2003;362:53-61.
2. Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin. Liver Dis 2003;7:759-777. vi.
3. Ishibashi H, Nakamnra M, Shimoda S, Gershwin ME. T cell immunity and primary biliary cirrhosis. Autoimmun Rev 2003;2:19-24.
4. Havdon GH, Neuberger J. PBC: an infectious disease? Gut 2000;47:586-588.
5. Rose NR, Mackay IR. Molecular mimiery: a critical look at exemplary instances in human diseases. Cell Mol Life Sci 2000;57:542-551.
6. Shi F, Ljunggren HG, Sarvetnick N. Innate immunity and autoimmunity: from self-protection to sell-destruction. Trends Immunol 2001;22: 97-101.
7. van den Berg TK, Yoder JA, Litman GW. On the origins of adaptive immunity: innate immune receptors join the tale. Trends Immunol 2004; 25:11-16.
8. Beutler B. Inferences, questions anel possibilities in Toll-like receptor signalling. Nature 2004;430:257-263.
9. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995.
10. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145.
11. Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Microbes Infect 2004;6:1382-1387.
12. Kikuchi K, Lian ZX, Yang GX, Ansari AA, Ikehara S, Kaplan M, et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005;128:304-312.
13. Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsupporative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978;379:103-112.
14. Moteki S, Leung PS, Coppel RL, Dickson ER, Kaplan MM, Munoz S, et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. HEPATOLOGY 1996;24:97-103.
15. Brown SB, Savill J. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosts of bystander leukocytes. J Immunol 1999;162:480-485.
16. Kiener PA, Davis PM, Starling GC, Mehlin C, Klebanoff SJ, Ledbetter JA, et al. Differential induction ol apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J Exp Med 1997;185:1511-1516.
17. Stoy NS. Monoyte/macrophage initiation of organ-specific autoimmunity: the ultimate 'bystander' hypothesis. Med Hypotheses 2002;58:312-326.
18. Hayasbi H, Smith KD. Ozinsky A, Hawn TR, Yi EC, Goodlett DR. et al. The innate immune response 10 bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099-1103.
19. Re F, Stromioger JL. Separate fuocitonal domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. J Immunol 2003;171:5272-5276.
20. Fitzgerld KA, Rowe DC, Goleobock DT. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect 2004;6: 1361-1367.
21. Ballot K, Bandin O, Chazouilleres O, Johanet C, Poupon R. Immune response to lipopulysaccharide in primary biliary cirrhosis and autoimmune diseases. J Autoimmun 2004;22:153-158.
22. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S. et al. Human TLR9 confers responsive-ness to baeterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 2001;98:9237-9242.
23. Tsuneyama K, Harada K, Kono N, Hiramatsu K, Zen Y, Strdo Y. et al. Seavenger cells with gram-positive bacterial lipoteichoic acid infilirate around the damaged interlobular bile duets of primary biliary cirrhosis. J Hepatol 2001;35:156-163.
24. Alexopoulon L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappB by-Toll-like receptor 3. Nature 2001;413:732-738.
25. Takii Y, Nakamura M, Ito M, Yokoyama T. Komori A, Shimizu-Yoshida Y, et al. Enhanced expession of type I interferon and roll-like receptor-3 in primary biliary cirrhosis. Lab Invest 2005;85:908-920.
26. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohon of patiems from the united states. Hepatology 2001;33:16-21.
27. Liew FY, Xu O, Brim EK, O'Neill LA. Negative regulation Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005;5: 446-458.
28. Harada K, Van de Water J, Lemg PS, Coppel RL, Ansari A, Nakanuma Y. et al. In situ nucleic acid hybridtzation of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. HEPATOLOGY 1997;25:791-796.
29. Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine paterns and cytotoxic mediators in primary biliary cirrhosis. HEPATOLOGY 1995;21:113-119.
30. Shiudo M, Mullin GE, Braun-Elwert L, Bergasa NV. Jones EA, James SP. Cytokine mRNA expression in ihe liver oi patients with primary biliary cirrhosis (PBC) and chronic hefxititis B (CHB). Clin Exp Immunol 1996; 105:254-259.
31. Nagano T, Yamamoto K, Matsumoto S, Okamoto R, Tagashira M, Ibuki N, et al. Cytokine profile in the liver of primary biliary cirrhosis, J Clin Immunol 1909;19:422-427.
32. Lohr HP, Schlaak JF, Gerken G, FLeischer B, Diettes HP, Mever zum Buschenfelde KH. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood Tlymphocytes from patients with chronic hepatitis of different etiology. Liver 1994;14:161-166.